Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9001447 | Biochemical Pharmacology | 2005 | 7 Pages |
Abstract
Drugs targeting retinoid receptors have been developed to treat a variety of therapeutic indications, but their success has been limited in part due to lack of selectivity. A novel functional cell-based assay R-SAT⢠was employed to screen a small molecule chemical library and identify a variety of novel RAR agonists with various subtype selectivities, including RARβ/γ and RARγ selective agonists. A novel class of synthetic compounds that distinguishes between the different RARβ isoforms is described. This pharmacophore displays anti-proliferative activity and induces differentiation in a neuronal cell line, consistent with a classical retinoid mechanism of action while providing unique subtype selectivity. These novel subtype selective RAR agonists could serve as powerful tools to probe into subtype and isoform-specific retinoid function.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Fabrice Piu, Natalie K. Gauthier, Roger Olsson, Erika A. Currier, Birgitte W. Lund, Glenn E. Croston, Uli Hacksell, Mark R. Brann,